Loading...
XSES
H02
Market cap2.33bUSD
Sep 17, Last price  
13.41SGD
1D
0.45%
1Q
-16.71%
Jan 2017
47.52%
Name

Haw Par Corporation Ltd

Chart & performance

D1W1MN
XSES:H02 chart
P/E
11.18
P/S
12.91
EPS
1.20
Div yield, %
10.44%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
15.68%
Revenues
230m
-6.07%
119,682,000119,332,000122,109,000123,991,000129,761,000132,675,000139,349,000141,176,000154,222,000178,834,000201,644,000222,763,000237,814,000243,987,000111,032,000141,180,000182,092,000232,062,000244,824,000229,967,000
Net income
265m
+16.29%
107,091,000158,983,00078,269,00057,036,000112,507,00079,808,000119,965,000107,919,000118,825,000183,276,000125,041,000122,460,000179,068,000182,207,000119,773,000110,103,000148,316,000216,569,000228,274,000265,462,000
CFO
271m
+404.39%
75,711,00092,366,00088,278,00082,380,00038,324,00057,978,00089,260,00094,611,00058,114,000127,662,00091,579,000106,855,000126,561,000199,071,00025,028,00018,841,00040,942,00062,684,00053,786,000271,292,000
Dividend
Aug 24, 20260.2 SGD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Singapore in 1969, Haw Par Corporation Limited specializes in the manufacturing, marketing, and global trade of healthcare products, serving markets in Singapore, ASEAN countries, other Asian regions, and beyond. The company's business activities are structured into three main segments: Healthcare, Investments, and Others. Its Healthcare segment primarily produces and distributes topical pain relief solutions, prominently featuring the Tiger Balm and Kwan Loong brands. The Investments segment focuses on acquiring publicly traded securities. Additionally, Haw Par owns and leases out a diverse portfolio of investment properties, comprising 45,324 square meters of commercial and industrial real estate across Singapore and Malaysia. The corporation also offers family and tourist-oriented leisure experiences, notably through oceanariums. Furthermore, it provides leasing services for land, buildings, and office spaces, in addition to offering management support.

Key people

Sien Hao Tarn
Group General Manager · since 2012
Say Suan Chow
Group Finance Controller · since 2019
Ah Kuan Han
Executive Non-Independent Director
President, Chief Executive Officer, Executive Director · since 2003
Director & General Manager - Manufacturing of Haw Par Healthcare Limited · since 2006
Jasmin Hong
General Manager - Marketing of Haw Par Healthcare Limited · since 2014
Chua Keeth
Deputy General Manager - Marketing of Haw Par Healthcare Limited · since 2011
Mui Lick Kow
Senior Manager - Quality & Regulatory Affairs of Healthcare
Wah Tong Ng
Deputy General Manager - Manufacturing of Healthcare · since 2013
Siew Leng Shiu
Group Internal Audit Manager · since 2014
Sung Tze Whang
General Manager - Underwater World Pattaya Ltd · since 2011
Kay Swee Lee
Legal Counsel & Company Secretary · since 2019
Choon Soo Chew
Non-Executive Independent Director · since 2019
Kia Ngee Chew
Non-Executive Independent Director · since 2011
Non-Executive Independent Director · since 2014
Non-Executive Independent Director · since 1986
Suan Yew Lee
Non-Executive Independent Director · since 1995
Non-Executive Independent Director · since 2011
IPO date
Jan 02, 1979
Employees
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT